Early use of intravitreal triamcinolone to inhibit traumatic proliferative vitreoretinopathy: a randomised clinical trial
CONCLUSIONS: Early intravitreal TA injection for OGI effectively reduces TPVR, increases surgical success and improves visual prognosis.PMID:38041678 | DOI:10.1136/bjo-2023-324318
Source: The British Journal of Ophthalmology - Category: Opthalmology Authors: Haixia Guo Jinguo Yu Tiangeng He Song Chen Zhuoyu Sun Jingkai Zhang Zhiyong Sun Wenhui Yang Baoqun Yao Xueli Yang Yuanyuan Liu Mingxue Zhang Yu Meng Likun Yang Hua Yan Source Type: research
More News: Clinical Trials | Emergency Medicine | Eyes | Men | Opthalmology | Sodium Chloride | Triamcinolone | UK Health | Vitamin A